Difficulty hearing speech in noisy rooms may be early sign of dementia

Experts are divided over whether treating

An impressively large study following more than 80,000 people for 11 years has found that difficulty hearing speech in noisy environments can be an early-warning sign of later-life dementia. The next steps for the research will be to investigate whether immediately treating mid-life hearing impairments can reduce the risk of dementia developing in a person’s senior years.

Continue Reading

Category: Health & Wellbeing, Lifestyle

Tags: , , , , , ,

Continue reading Difficulty hearing speech in noisy rooms may be early sign of dementia

Metal, microbubbles and ultrasound combine to fight Alzheimer’s plaques

Brain imaging shows the accumulation of a metal-based molecule in the region of the brain targeted with ultrasound

Among the more interesting ways scientists hope to tackle the roots of Alzheimer’s disease is by using microbubbles to prise open the blood brain barrier and sneak in drugs that bust apart toxic plaques. A team in the UK has found new success using this experimental approach, demonstrating how the technique can be combined with ultrasound and a novel metal-based molecule to prevent this type of plaque buildup in its early stages.

Continue Reading

Category: Medical, Science

Tags: , , , ,

Continue reading Metal, microbubbles and ultrasound combine to fight Alzheimer’s plaques

Metal, microbubbles and ultrasound combine to fight Alzheimer’s plaques

Brain imaging shows the accumulation of a metal-based molecule in the region of the brain targeted with ultrasound

Among the more interesting ways scientists hope to tackle the roots of Alzheimer’s disease is by using microbubbles to prise open the blood brain barrier and sneak in drugs that bust apart toxic plaques. A team in the UK has found new success using this experimental approach, demonstrating how the technique can be combined with ultrasound and a novel metal-based molecule to prevent this type of plaque buildup in its early stages.

Continue Reading

Category: Medical, Science

Tags: , , , ,

Continue reading Metal, microbubbles and ultrasound combine to fight Alzheimer’s plaques

Dementia-fighting experimental drug moves to human trials

A new drug called SAK3 has shown promising preclinical results in animal models of Alzheimer's and Lewy Body dementia

After years of preclinical work, Japanese researchers have announced a new kind of drug treatment for dementia and Alzheimer’s disease is ready to move to human clinical trials. A number of animal studies have shown the novel drug to improve cognition and reduce signs of neurodegeneration in a number of dementia-causing diseases.

Continue Reading

Category: Health & Wellbeing, Lifestyle

Tags: , , , , , ,

Continue reading Dementia-fighting experimental drug moves to human trials

Ultrasound boosts memory of aging mice in Alzheimer’s study

Ultrasound may be a way to not just tackle brain plaques associated with Alzheimer's, but also age-related cognitive decline in the broader population

One promising possibility when it comes to treating Alzheimer’s is the idea of using non-invasive ultrasound to take out toxic brain plaques, and a group of researchers in Australia have been at the cutting edge of this technology for a number of years. The scientists’ latest investigations have uncovered some surprising new ways this technique can improve cognition in mouse models of the disease, which they believe could have wider implications for restoring cognition in the elderly.

Continue Reading

Category: Medical, Science

Tags: , , , , ,

Continue reading Ultrasound boosts memory of aging mice in Alzheimer’s study

FDA Alzheimer’s call slammed as “Worst drug approval in recent US history”

The recent FDA approval for a new Alzheimer's drug raises questions over what factors the regulatory body should take into account when authorizing new medicines

The US Food and Drug Administration’s controversial recent approval of Alzheimer’s drug Aduhelm has been subject to vociferous criticism from many in the scientific community. Amidst concerns surrounding the drug’s efficacy and price, several expert advisors to the FDA have resigned in protest and calls for top officials to step down are growing.

Continue Reading

Category: Science

Tags: , ,

Continue reading FDA Alzheimer’s call slammed as “Worst drug approval in recent US history”

First brain observations of faulty memory sheds light on Alzheimer’s

Scientists have used experiments on rats to identify specific patterns of brain cell activity that can relate to correct and incorrect memories

Through a new study on rodents, scientists have made first-of-a-kind observations of the brain mistakenly recalling a memory. The researchers were able to identify patterns of brain cell activation as mistakes were made during memory experiments, which the scientists believe lays the groundwork for understanding the mechanisms at play in memory disorders such as Alzheimer’s disease.

Continue Reading

Category: Medical, Science

Tags: , , , ,

Continue reading First brain observations of faulty memory sheds light on Alzheimer’s

Blood biomarker detects whether depression is due to neurodegeneration

A test could be used as a rapid screening tool in clinics to determine whether a patient's cognitive problems are due to neurodegeneration.

A new study published in the journal Nature Communications is reporting a single blood-based biomarker can detect the presence of 13 neurodegenerative disorders, from frontotemporal dementia to motor neuron disease. The test cannot specifically distinguish each disorder but instead is proposed as a way to determine whether patients with memory problems are suffering from the early stages of neurodegenerative disease.

Continue Reading

Category: Medical, Science

Tags: , , , , , , ,

Continue reading Blood biomarker detects whether depression is due to neurodegeneration

First new Alzheimer’s drug in decades receives controversial FDA approval

Approval of a new Alzheimer's drug comes after a FDA advisory panel last year overwhelmingly concluded there is not enough evidence to claim it is effective

A new Alzheimer’s disease treatment has been controversially approved for use in the United States despite an independent Food and Drug Administration (FDA) advisory panel reporting last year the drug’s Phase 3 trial results were inconclusive. The approval marks the first new treatment for Alzheimer’s in almost 20 years.

Continue Reading

Category: Health & Wellbeing, Lifestyle

Tags: , , , ,

Continue reading First new Alzheimer’s drug in decades receives controversial FDA approval

Massive blood sampling study identifies predictors of Alzheimer’s risk

Scientists have identified a new set of blood-based biomarkers that may help predict Alzheimer's risk

While the exact causes behind Alzheimer’s are still unknown, research is beginning to demonstrate how biomarkers of the disease might reveal themselves long before symptoms appear, raising the prospect of earlier diagnosis and better treatments for patients. A new study, claimed to be the most comprehensive of its type, has demonstrated how concentrations of certain proteins in the blood might indicate the onset of the condition far in advance, and has pinpointed one that may even help trigger it.

Continue Reading

Category: Medical, Science

Tags: , , , ,

Continue reading Massive blood sampling study identifies predictors of Alzheimer’s risk